Colchicine use is associated with a modest reduction in the long-term risk for total joint arthroplasty (TJA) among individuals with gout, according to study findings published in Arthritis & ...

Historical use of colchicine, or its precursors, dates back several thousand years, with reports appearing in records from ancient Egyptians, Greeks and Arabic physicians. Although colchicine has been ...

Colchicine does not significantly reduce perioperative atrial fibrillation (AF) or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery, ...

NEW YORK — New insights into colchicine's disruption of the pathway that contributes to arterial inflammation and new clinical studies of the drug could pave the way toward greater use of the ...

Please provide your email address to receive an email when new articles are posted on . In a meta-analysis of seven trials, colchicine was associated with reduced risk for MACE in patients with CAD ...

Colchicine is one of the oldest medicines with potent anti-inflammatory functions, widely used to treat rheumatic diseases such as gout, calcium pyrophosphate deposition disease (CPDD), and familial ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Treatment with ...

WASHINGTON — Colchicine does not protect against major cardiovascular adverse events after an acute myocardial infarction, according to a multinational placebo-controlled trial of more than 7000 ...

NEW YORK (Reuters Health) - The gout drug colchicine is safe for women to take during pregnancy, report researchers from Israel. In addition to the debilitating joint disorder gout, the ...

(Reuters Health) - The inflammation-fighting drug colchicine, already a treatment for gout, dramatically reduces the odds of future cardiovascular problems in people who have just survived a heart ...

Colchicine fails to protect against myocardial injury in STEMI when given at the time of reperfusion then continued for 5 days after, according to data from the randomized COVERT-MI. There also is a ...